Adjuvant Concurrent Chemoradiotherapy vs. Radiotherapy Alone in Cervical Cancer Patients with Intermediate-Risk Factors after Radical Surgery

被引：0
|
作者：
Zhou, Y. [1 ]
Hu, K. [2 ]
Zhang, F. Q. [3 ]
机构：
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Radiat Oncol, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3226
引用
收藏
页码：E560 / E560
页数：1
相关论文
共 50 条
  • [1] Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
    Kim, Hakyoung
    Park, Won
    Kim, Young Seok
    Kim, Yeon Joo
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (03)
  • [2] Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis
    Li, Meng
    Hu, Mengyang
    Wang, Yuanjian
    Yang, Xingsheng
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 238 : 1 - 6
  • [3] Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery
    Zhou, Yuncan
    Wang, Weiping
    Tang, Jia
    Hu, Ke
    Zhang, Fuquan
    [J]. BMC CANCER, 2024, 24 (01)
  • [4] Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer
    Sebastian, Nikhil T.
    McElroy, Joseph P.
    Martin, Douglas D.
    Sundi, Debasish
    Diaz, Dayssy Alexandra
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 813.e11 - 813.e19
  • [5] Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
    Sun, Hai-Yan
    Tang, Qiu
    Chen, Jian-Hong
    Lv, Xiao-Juan
    Tu, Ye-Qiang
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 1149 - 1155
  • [6] Sequential Chemoradiotherapy vs Concurrent Chemoradiotherapy or Radiotherapy Alone in AdjuvantTreatment for Patients With Cervical Cancer Reply
    Huang, He
    Feng, Yan-Ling
    Liu, Ji-Hong
    [J]. JAMA ONCOLOGY, 2021, 7 (09) : 1404 - +
  • [7] Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
    Sun, Wenze
    Wang, Tao
    Shi, Fan
    Wang, Jiquan
    Wang, Juan
    Hui, Beina
    Zhang, Yingbing
    Lu, Jinli
    Chen, Hongwei
    Liu, Zi
    [J]. BMC CANCER, 2015, 15
  • [8] Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
    Wenze Sun
    Tao Wang
    Fan Shi
    Jiquan Wang
    Juan Wang
    Beina Hui
    Yingbing Zhang
    Jinli Lu
    Hongwei Chen
    Zi Liu
    [J]. BMC Cancer, 15
  • [9] Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy?
    Yahata, Hideaki
    Sonoda, Kenzo
    Inoue, Shusaku
    Yasutake, Nobuko
    Kodama, Keisuke
    Yagi, Hiroshi
    Yasunaga, Masafumi
    Ohgami, Tatsuhiro
    Onoyama, Ichiro
    Kaneki, Eisuke
    Okugawa, Kaoru
    Asanoma, Kazuo
    Kato, Kiyoko
    [J]. ONCOLOGY, 2020, 98 (12) : 853 - 858
  • [10] Risk factors of recurrence after adjuvant concurrent chemoradiotherapy following radical hysterectomy in high-risk patients with cervical cancer
    Chung, H.
    Kim, J.
    Park, N.
    Song, Y.
    Kang, S.
    Lee, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345